 |
 Integrated
Science
Target identification
We are developing new technologies and science to identify the “signature
of cancer” by profiling the molecular differences between normal
and cancer cells. A systems approach reveals how a cell is wired to function
as an integrated system, what goes awry when diseases develop, and what
key molecular targets can be used to assess these changes – molecular
imaging diagnostics - for guiding the correction of molecular errors of
disease.

Molecular
Probe development
Molecular probes are tool sets used to run tests on the biology of cells
and organ systems – the way mechanics run diagnostics to repair
our cars. These tool sets can be arrays of small molecules, such as sugars
and amino acids, or larger molecules such as antibodies and proteins.
Crump Institute scientists are inventing technologies and processes to
streamline approaches to select, synthesize, and evaluate probes that
will allow us to watch and measure the molecular basis of normal cellular
function and the transition to disease.
Living cells
Tumors contain a diverse mix of cells such as the various types of cancer
cells, blood vessels, and immune cells; the function of the immune system
is orchestrated by specialized collections of cells that communicate and
work together to organize their attack on a tumor. Using miniaturized
laboratories on chips being developed in the Crump Institute, we can investigate
biology at the level of the individual cell, answering specific questions
about how a communication pathway is activated or can be silenced by shutting
off a switch using a targeted therapy.

Living organisms
Molecular imaging allows us to watch, measure, and interrogate biological
processes, in the intact living organism in a non-invasive and safe manner.
We can ask not just what, but where, when, and how much is the biology
changing, as disease develops and as we intervene to drive the disease
biology back towards normal or eliminate it. Our ultimate goal is to provide
the means to be able to ask these questions in patients, in order to truly
understand and effectively treat disease.
|
 |